跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Brelvastin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Brelvastin
Approved
STANDARD
Brelvastin
Kausikh Therapeutics (P) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9c74f1e1a424b34c
Company
Kausikh Therapeutics (P) Ltd.
Type
Standard
Approval Details
Approval Id
9c74f1e1a424b34c
Drug Approval Philippines Name
Brelvastin
Product Name
Brelvastin
Registration Number
DRP-4640
Brand Name
Brelvastin
Generic Name
Atorvastatin (as calcium)
Dosage Form
Film-Coated Tablet
Dosage Strength
40 mg
Manufacturer
Kausikh Therapeutics (P) Ltd.
Importer
Brel Pharmaceutical, Inc.
Distributor
Brel Pharmaceutical, Inc.
Issuance Date
25 May 2025
Expiry Date
29 August 2031
Pharmacologic Category
HMG-CoA Reductase inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9c74f1e1a424b34c
Type
Standard
Back to Philippines FDA Approvals